DELFI (DNA evaluation of fragments for early interception)
DELFI (DNA evaluation of fragments for early interception) is a new medical test approach that can help detect over 90 per cent of cancers by recognizing unique fragmentation of DNA shed from cancer cells circulating in the bloodstream.
The novel approach was tested in nearly 800 individuals from Denmark, Netherlands and the US. It was able to accurately distinguish between patients with and without lung cancer. It was able to accurately detect from 91 per cent of patients with cancer at earlier or less invasive stage and 96 per cent of patients with more advanced stage.